and also acts as an anticancer by decreasing expression of CSCs and myofibroblast markers, suppressing proliferation and mitosis and has also been shown to reduce drug resistance (Ajmal et al., 2019
This is mechanistically demonstrated in breast cancer models, where SFN, by activating the Nrf2 pathway, reduces the secretion of prostaglandin E2 (PGE2) from tumor cells, thereby triggering MDSCs to switch from an immunosuppressive to an immunogenic phenotype and inhibiting their expansion (76)
Evidencia cientfica La evidencia que respalda el inters en KLOW procede de estudios preclnicos e in vitro sobre cada uno de sus cuatro pptidos, no de ensayos clnicos del blend como tal, algo que debe subrayarse dentro de su marco de investigacin (RUO)
Their place in a weight-loss practice GLP-1 medications are powerful, but they are one component of a comprehensive program, not the program itself